Cell-penetrating peptide exploited syndecans

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 12, 2010, Pages 2258-2265

  Letoha, Tamás ^a,b   Keller Pintér, Anikó ^c   Kusz, Erzsébet ^a   Kolozsi, Csongor ^a   Bozsó, Zsolt ^c   Tóth, Gábor ^c   Vizler, Csaba ^a   Oláh, Zoltán ^b,d   Szilák, László ^e,f  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b Pharmacoidea Ltd   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Acheuron Hungary Ltd   (Hungary)

^e Szilak Laboratories Bioinformatics and Molecule Design   (Hungary)

^f UNIVERSITY OF WEST HUNGARY   (Hungary)

Author keywords

Cell penetrating peptides; Heparan sulfate proteoglycans; Intracellular delivery; Protein kinase C alpha; Syndecans

Indexed keywords

CELL PENETRATING PEPTIDE; OCTAARGININE; PENETRATIN; PROTEIN KINASE C ALPHA; PROTEOHEPARAN SULFATE; SYNDECAN 4; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE TRANSPORT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS;

CELL MEMBRANE; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; HEPARITIN SULFATE; HUMANS; K562 CELLS; PROTEIN ISOFORMS; PROTEIN KINASE C-ALPHA; PROTEIN TRANSPORT; SYNDECAN-4;

EID: 77958151610     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.01.022     Document Type: Article

References (66)

1. Deshayes S., Morris M.C., Divita G., Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 2005, 62:1839-1849.
2. Foged C., Nielsen H.M. Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin. Drug Deliv. 2008, 5:105-117.
3. Jarver P., Langel U. Cell-penetrating peptides-a brief introduction. Biochim. Biophys. Acta 2006, 1758:260-263.
4. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000, 21:99-103.
5. Morris M.C., Deshayes S., Heitz F., Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell 2008, 100:201-217.
6. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157:195-206.
7. Deshayes S., Morris M., Heitz F., Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Deliv. Rev. 2008, 60:537-547.
8. Meade B.R., Dowdy S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev. 2008, 60:530-536.
9. Stewart K.M., Horton K.L., Kelley S.O. Cell-penetrating peptides as delivery vehicles for biology and medicine. Org. Biomol. Chem. 2008, 6:2242-2255.
10. Vives E., Schmidt J., Pelegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim. Biophys. Acta 2008.
11. Edenhofer F. Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Curr. Pharm. Des. 2008, 14:3628-3636.
12. Ghibaudi E., Boscolo B., Inserra G., Laurenti E., Traversa S., Barbero L., Ferrari R.P. The interaction of the cell-penetrating peptide penetratin with heparin, heparansulfates and phospholipid vesicles investigated by ESR spectroscopy. J. Pept. Sci. 2005, 11:401-409.
13. Nakase I., Tadokoro A., Kawabata N., Takeuchi T., Katoh H., Hiramoto K., Negishi M., Nomizu M., Sugiura Y., Futaki S. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 2007, 46:492-501.
14. Nakase I., Takeuchi T., Tanaka G., Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008, 60:598-607.
15. Poon G.M., Gariepy J. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem. Soc. Trans. 2007, 35:788-793.
16. Ziegler A., Seelig J. Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds. Biophys. J. 2008, 94:2142-2149.
17. Console S., Marty C., Garcia-Echeverria C., Schwendener R., Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT), "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J.Biol. Chem. 2003, 278:35109-35114.
18. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., Brock R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007, 8:848-866.
19. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 2005, 280:15300-15306.
20. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
21. Iozzo R.V. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J. Clin. Invest. 2001, 108:165-167.
22. Park P.W., Reizes O., Bernfield M. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 2000, 275:29923-29926.
23. Tumova S., Woods A., Couchman J.R. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 2000, 32:269-288.
24. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68:729-777.
25. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., Lose E.J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 1992, 8:365-393.
26. Kokenyesi R., Bernfield M. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J. Biol. Chem. 1994, 269:12304-12309.
27. McFall A.J., Rapraeger A.C. Identification of an adhesion site within the syndecan-4 extracellular protein domain. J. Biol. Chem. 1997, 272:12901-12904.
28. Rapraeger A.C., Ott V.L. Molecular interactions of the syndecan core proteins. Curr. Opin. Cell Biol. 1998, 10:620-628.
29. Keum E., Kim Y., Kim J., Kwon S., Lim Y., Han I., Oh E.S. Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha. Biochem. J. 2004, 378:1007-1014.
30. Oh E.S., Woods A., Couchman J.R. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 1997, 272:8133-8136.
31. Oh E.S., Woods A., Couchman J.R. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J. Biol. Chem. 1997, 272:11805-11811.
32. Tkachenko E., Rhodes J.M., Simons M. Syndecans: new kids on the signaling block. Circ. Res. 2005, 96:488-500.
33. Yoneda A., Couchman J.R. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 2003, 22:25-33.
34. Tkachenko E., Lutgens E., Stan R.V., Simons M. Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J. Cell Sci. 2004, 117:3189-3199.
35. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., Lindsay M.A. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 2005, 145:1093-1102.
36. Kaplan I.M., Wadia J.S., Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release 2005, 102:247-253.
37. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 2004, 10:310-315.
38. Paris S., Burlacu A., Durocher Y. Opposing roles of syndecan-1 and syndecan-2 in polyethyleneimine-mediated gene delivery. J. Biol. Chem. 2008, 283:7697-7704.
39. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
40. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 1996, 271:18188-18193.
41. Derossi D., Chassaing G., Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 1998, 8:84-87.
42. Jones A.T. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. Int. J. Pharm. 2008, 354:34-38.
43. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 2003, 278:585-590.
44. Fulop L., Penke B., Zarandi M. Synthesis and fluorescent labeling of beta-amyloid peptides. J. Pept. Sci. 2001, 7:397-401.
45. Busetto S., Trevisan E., Patriarca P., Menegazzi R. A single-step, sensitive flow cytofluorometric assay for the simultaneous assessment of membrane-bound and ingested Candida albicans in phagocytosing neutrophils. Cytometry A 2004, 58:201-206.
46. Letoha T., Gaal S., Somlai C., Venkei Z., Glavinas H., Kusz E., Duda E., Czajlik A., Petak F., Penke B. Investigation of penetratin peptides. Part 2. In vitro uptake of penetratin and two of its derivatives. J. Pept. Sci. 2005, 11:805-811.
47. Fadel S., Eley A. Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells. J. Med. Microbiol. 2004, 53:93-95.
48. Muro S., Wiewrodt R., Thomas A., Koniaris L., Albelda S.M., Muzykantov V.R., Koval M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J. Cell Sci. 2003, 116:1599-1609.
49. Attisano L., Wrana J.L., Lopez-Casillas F., Massague J. TGF-beta receptors and actions. Biochim. Biophys. Acta 1994, 1222:71-80.
50. Shafti-Keramat S., Handisurya A., Kriehuber E., Meneguzzi G., Slupetzky K., Kirnbauer R. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J. Virol. 2003, 77:13125-13135.
51. Safaiyan F., Kolset S.O., Prydz K., Gottfridsson E., Lindahl U., Salmivirta M. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 1999, 274:36267-36273.
52. Couchman J.R., Vogt S., Lim S.T., Lim Y., Oh E.S., Prestwich G.D., Theibert A., Lee W., Woods A. Regulation of inositol phospholipid binding and signaling through syndecan-4. J. Biol. Chem. 2002, 277:49296-49303.
53. Koo B.K., Jung Y.S., Shin J., Han I., Mortier E., Zimmermann P., Whiteford J.R., Couchman J.R., Oh E.S., Lee W. Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling. J. Mol. Biol. 2006, 355:651-663.
54. Jones A.T. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell. Mol. Med. 2007, 11:670-684.
55. Joliot A. Transduction peptides within naturally occurring proteins. Sci. STKE 2005, 2005:e54.
56. Prochiantz A. Homeodomain-derived peptides. In and out of the cells. Ann. N. Y. Acad. Sci. 1999, 886:172-179.
57. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 2000, 12:400-406.
58. Joliot A., Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 2004, 6:189-196.
59. Wadia J.S., Dowdy S.F. Protein transduction technology. Curr. Opin. Biotechnol. 2002, 13:52-56.
60. Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 2002, 245:1-7.
61. Futaki S., Nakase I., Tadokoro A., Takeuchi T., Jones A.T. Arginine-rich peptides and their internalization mechanisms. Biochem. Soc. Trans. 2007, 35:784-787.
62. Kosuge M., Takeuchi T., Nakase I., Jones A.T., Futaki S. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug. Chem. 2008, 19:656-664.
63. Zako M., Dong J., Goldberger O., Bernfield M., Gallagher J.T., Deakin J.A. Syndecan-1 and -4 synthesized simultaneously by mouse mammary gland epithelial cells bear heparan sulfate chains that are apparently structurally indistinguishable. J. Biol. Chem. 2003, 278:13561-13569.
64. Choi S., Lee E., Kwon S., Park H., Yi J.Y., Kim S., Han I.O., Yun Y., Oh E.S. Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4. J. Biol. Chem. 2005, 280:42573-42579.
65. Simons M., Horowitz A. Syndecan-4-mediated signalling. Cell. Signal. 2001, 13:855-862.
66. Son H., Lim Y., Kim J., Park H., Choi S., Han I., Kim W.S., Park S., Bae Y., Oh E.S. Protein kinase Calpha can undergo membrane localization via an alternative phosphatidylinositol 4, 5-bisphosphate-dependent pathway. Arch. Biochem. Biophys. 2006, 454:1-6.